ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Effect of Intermittent Aldesleukin Treatment With or Without Anti-HIV Drugs in HIV Infected People

ClinicalTrials.gov ID: NCT00110812

Public ClinicalTrials.gov record NCT00110812. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 7:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

STALWART: A Randomized, Open-Label, International Study of Subcutaneous Recombinant Interleukin-2 With and Without Concomitant Antiretroviral Therapy in Patients With HIV-1 Infection and CD4+ Cell Counts of 300 Cells/mm3 or More

Study identification

NCT ID
NCT00110812
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
267 participants

Conditions and interventions

Conditions

Interventions

  • IL-2 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2005
Primary completion
Jan 31, 2011
Completion
Jan 31, 2011
Last update posted
Nov 3, 2021

2005 – 2011

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
VA Greater Los Angeles Healthcare System, Infectious Diseases Section CRS Los Angeles California 90073
Washington DC VAMC, Washington Regional AIDS Program, Infectious Diseases CRS Washington D.C. District of Columbia 20422
NIH Clinical Ctr., NIAID HIV Clinic CRS Bethesda Maryland 20814-9692
Henry Ford Hosp. CRS Detroit Michigan 48202
Harlem Hospital Ctr./Columbia University CRS (Gordin CTU) New York New York 10037
Lincoln Hosp. & Med. Ctr. CRS The Bronx New York 10451
Providence Portland Med. Ctr., Ambulatory Care and Education Ctr. CRS Portland Oregon 97213
Michael E. DeBakey VAMC CRS Houston Texas 77030
Thomas Street Clinic CRS Houston Texas 77030
South Texas Veterans Health Care System, Immunosuppression Clinic CRS San Antonio Texas 78229
Virginia Commonwealth Univ. Medical Ctr. CRS Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00110812, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00110812 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →